Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,127 | -16,306 | N/A | N/A | N/A |
| Depreciation Amortization | 95 | 27 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 345 | -205 | N/A | N/A | N/A |
| Other Working Capital | -879 | 2,114 | N/A | N/A | N/A |
| Other Operating Activity | 1,423 | 616 | 0 | 0 | 0 |
| Operating Cash Flow | $-21,143 | $-13,754 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,775 | -211 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,775 | $-211 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 59,900 | 111 | N/A | N/A | N/A |
| Other Financing Activity | 27,803 | -226 | 0 | 0 | 0 |
| Financing Cash Flow | $87,703 | $-115 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 10,137 | 24,217 | N/A | N/A | N/A |
| End Cash Position | 74,922 | 10,137 | N/A | N/A | N/A |
| Net Cash Flow | $64,785 | $-14,080 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,143 | -13,754 | N/A | N/A | N/A |
| Capital Expenditure | -1,775 | -211 | N/A | N/A | N/A |
| Free Cash Flow | -22,918 | -13,965 | 0 | 0 | 0 |